Le Lézard
Classified in: Health, Science and technology, Business
Subject: FNC

BANK INVESTMENT AIMS TO IMPROVE REVENUE CYCLE FOR HEALTHCARE INDUSTRY


Huntington Bancshares Incorporated, Veuu to create AI-based solutions to address pain points

COLUMBUS, Ohio, Sept. 7, 2023 /PRNewswire/ -- Huntington Bancshares Incorporated has invested in Veuu, a healthcare fintech, to develop artificial intelligence-based solutions to revenue cycle challenges common within the healthcare industry.

The investment brings together Huntington's healthcare banking experience and Veuu's AI expertise to produce innovation that solves key revenue cycle pain points, such as lengthy outstanding accounts receivable, increasing denials, rising labor expenses, costly back-office functions and compliance risks?all of which create financial and operating challenges for healthcare providers, payors and the patients they serve.

"For years, we've heard from our physician and hospital clients about the difficulties they experience with the revenue cycle and limitations to working capital financing, so we decided to team up with Veuu to develop solutions that address the complex root cause: medical coding errors," said Dan Storer, Huntington's senior managing director of healthcare banking. "No single stakeholder in healthcare can solve the downstream consequences like claim denials and expensive financing options?not the providers, payors, government, technology companies or financial institutions. These digital innovations require collaboration and strong partnership, and our relationship with Veuu strategically positions us to be able to tackle many of these challenges."

"In collaboration with Huntington, we seek to provide a compelling future state through AI technology for some of the costliest problems in healthcare," added Terence Mills, CEO of Veuu. "With the size and depth of the problems growing, the right partnership is vital for acceptance and adoption in an otherwise complex industry. Huntington's commitment and proven track record in healthcare banking make them the ideal strategic partner for Veuu."

The equity investment was led by Huntington Corporate Ventures, an internal team focused on developing and executing partnerships, investments and new ventures that accelerate the momentum of Huntington's business segments.

About Huntington
Huntington Bancshares Incorporated (Nasdaq: HBAN) is a $189 billion asset regional bank holding company headquartered in Columbus, Ohio. Founded in 1866, The Huntington National Bank and its affiliates provide consumers, small and middle?market businesses, corporations, municipalities, and other organizations with a comprehensive suite of banking, payments, wealth management, and risk management products and services. Huntington operates more than 1,000 branches in 11 states, with certain businesses operating in extended geographies. Visit Huntington.com for more information.

About Veuu
Based in Tampa, Veuu is an inclusive and sustainable fintech ecosystem for healthcare that allows for providers to adjudicate patients at discharge. The Veuu ecosystem contains a suite of AI tools that automate and de-risk so that providers can be paid based at negotiated rate the day that the patient leaves the hospital. Visit Veuu.com for more information.

SOURCE Huntington Bancshares Inc.


These press releases may also interest you

at 00:05
Corsearch, leading provider of brand protection and trademark solutions, has today shared research predicting that the size of the global trade in counterfeit goods could reach $1.79 trillion by 2030, a 75% increase from that of 2023 and a growth 3.6...

at 00:01
Celltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult patients...

16 mai 2024
OKX, a leading Web3 technology company, has issued updates for May 16, 2024. OKX Launches Cryptopedia Season 18, Offering Users Up to...

16 mai 2024
Mr. Narongsak Jivakanun (Second from left), CEO of PTT Global Chemical Public Company Limited (GC) presided over the signing ceremony and extended his congratulations to Krungthai Bank and NatureWorks - a joint venture of GC and a leading...

16 mai 2024
Two of Tianma's advanced technology displays introduced at Display Week 2024 ? the 13" Dynamic Flexible OLED and the 12.3"...

16 mai 2024
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson for $850 million in cash,...



News published on and distributed by: